Reply to Letter to the Editor on disease severity and efficacy of homologous vaccination among patients infected with SARS-CoV-2 Delta or Omicron VOCs, compared to unvaccinated using main biomarkers.

Ali, Ayad M; Tofiq, Ahmed M; Rostam, Hassan M; Ali, Kameran M; Tawfeeq, Hassan M

Ali, Ayad M; Tofiq, Ahmed M; Rostam, Hassan M; Ali, Kameran M; Tawfeeq, Hassan M.

Afiliação

Ali AM; Department of Chemistry, University of Garmian, Kalar, Kurdistan Region, Iraq.
Tofiq AM; Department of Biology, College of Education, Head of International Academic Relations (IRO), University of Garmian, Kalar, Kurdistan Region, Iraq.
Rostam HM; Immunology and Immuno Bioengineering Group, Infections, Immunity and Microbes Division, School of Life Sciences, Faculty of Medicine and Health Sciences, University of Nottingham, Nottingham, UK.
Ali KM; Department of Medicine, College of Medicine, University of Garmian, Kalar, Kurdistan Region, Iraq.
Tawfeeq HM; Medical Lab Technology Department, Kalar Technical College, Sulaimani Polytechnic University, Kalar, Kurdistan Region, Iraq.

J Med Virol ; 95(1): e28313, 2023 01.

Article em En | MEDLINE | ID: mdl-36380449

Assuntos

COVID-19; SARS-CoV-2; Humanos; COVID-19/prevenção & controle; Gravidade do Paciente

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 1_ASSA2030 / 2_ODS3 / 4_TD Base de dados: MEDLINE Assunto principal: SARS-CoV-2 / COVID-19 Limite: Humans Idioma: En Revista: J Med Virol Ano de publicação: 2023 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google